Cambridge, MA (PRWEB) March 16, 2015
The ALS Therapy Development Institute (ALS.net), through its Young Faces of ALS campaign, today announced the fifth annual “National Corntoss Challenge” events being held this summer in seven cities throughout the country. The National Corntoss Challenge events fund ALS research taking place at the ALS Therapy Development Institute based in Cambridge, MA, a nonprofit biotech focused entirely on developing treatments and a cure for amyotrophic lateral sclerosis (ALS).
Each National Corntoss Challenge location will feature a day-long tournament of the popular game, corntoss, also known as cornhole, as well as entertainment, food, beverages and prizes. National sponsors include North Point Trust Company LLC and Taylor Farms.
This year’s National Corntoss Challenge events will be held in Boise, Boston, Minneapolis, New York, San Francisco, Seattle and Washington, DC, and are organized by ambassadors and members of the Young Faces of ALS campaign, a group that includes people living with ALS, their family members and friends who are under the age of 35 and are passionate to raise awareness of ALS and help fund research for a cure.
In the past four years, the National Corntoss Challenge has raised nearly $750,000 and engaged over 3,500 players and 17 participating cities from coast to coast. This year’s fundraising goal is $300,000. All funds benefit ALS research at the ALS Therapy Development Institute, whose scientists actively discover and develop treatments to end ALS.
“The young people who lead the Young Faces of ALS campaign were instrumental in fueling the Ice Bucket Challenge phenomenon last summer, helping to raise more than $200 million for ALS charities worldwide,” says Steve Perrin, Ph.D., CEO and Chief Scientific Officer at the ALS Therapy Development Institute. “The National Corntoss Tournaments enable people to continue to be inspired and stay involved in the fight to end ALS.”
To participate in a Corntoss Challenge, donate or learn more about the YFALS campaign, visit http://www.yfals.com.
About the ALS Therapy Development Institute
The ALS Therapy Development Institute and its scientists actively discover and develop treatments for ALS. The Institute is the world’s first and largest nonprofit biotech focused 100 percent on ALS research. Led by ALS patients and their families, the charity understands the urgent need to slow and stop this horrible disease. Based in Cambridge, MA, the Institute has served as one of the leaders in sharing data and information with academic and ALS research organizations, patients and their families. For more information, visit http://www.als.net.
Media Contact: Mari Cody, ALS Therapy Development Institute, mcody(AT)als.net, (617) 441-7220